Source link : https://newshealth.biz/health-news/automated-insulin-delivery-tech-okayed-for-type-2-diabetes/
The US Food and Drug Administration (FDA) has expanded the indication for Tandem Diabetes Care’s Control-IQ+ Technology to include people with type 2 diabetes (T2D). The next-generation Control-IQ+ algorithm, used to enable automated insulin delivery (AID) in conjunction with Tandem’s t:slim X2 and Mobi insulin pumps, was already approved for people with type 1 diabetes […]
Author : News Health
Publish date : 2025-02-26 11:18:53
Copyright for syndicated content belongs to the linked Source.